1 Report Overview
1.1 Study Scope
1.2 Key Market Segments
1.3 Players Covered: Ranking by Advanced Cell Therapies Revenue
1.4 Market Analysis by Type
1.4.1 Global Advanced Cell Therapies Market Size Growth Rate by Type: 2020 VS 2026
1.4.2 Stem Cell Transplants
1.4.3 CAR T-cell Therapy
1.5 Market by Application
1.5.1 Global Advanced Cell Therapies Market Share by Application: 2021-2026
1.5.2 Stem Cell
1.5.3 Regenerative Medicine
1.6 Study Objectives
1.7 Years Considered
1.8 Overview of Global Advanced Cell Therapies Market
1.8.1 Global Advanced Cell Therapies Market Status and Outlook (2015-2026)
1.8.2 North America
1.8.3 East Asia
1.8.4 Europe
1.8.5 South Asia
1.8.6 Southeast Asia
1.8.7 Middle East
1.8.8 Africa
1.8.9 Oceania
1.8.10 South America
1.8.11 Rest of the World
2 Market Competition by Manufacturers
2.1 Global Advanced Cell Therapies Production Capacity Market Share by Manufacturers (2015-2020)
2.2 Global Advanced Cell Therapies Revenue Market Share by Manufacturers (2015-2020)
2.3 Global Advanced Cell Therapies Average Price by Manufacturers (2015-2020)
2.4 Manufacturers Advanced Cell Therapies Production Sites, Area Served, Product Type
3 Sales by Region
3.1 Global Advanced Cell Therapies Sales Volume Market Share by Region (2015-2020)
3.2 Global Advanced Cell Therapies Sales Revenue Market Share by Region (2015-2020)
3.3 North America Advanced Cell Therapies Sales Volume
3.3.1 North America Advanced Cell Therapies Sales Volume Growth Rate (2015-2020)
3.3.2 North America Advanced Cell Therapies Sales Volume Capacity, Revenue, Price and Gross Margin (2015-2020)
3.4 East Asia Advanced Cell Therapies Sales Volume
3.4.1 East Asia Advanced Cell Therapies Sales Volume Growth Rate (2015-2020)
3.4.2 East Asia Advanced Cell Therapies Sales Volume Capacity, Revenue, Price and Gross Margin (2015-2020)
3.5 Europe Advanced Cell Therapies Sales Volume (2015-2020)
3.5.1 Europe Advanced Cell Therapies Sales Volume Growth Rate (2015-2020)
3.5.2 Europe Advanced Cell Therapies Sales Volume Capacity, Revenue, Price and Gross Margin (2015-2020)
3.6 South Asia Advanced Cell Therapies Sales Volume (2015-2020)
3.6.1 South Asia Advanced Cell Therapies Sales Volume Growth Rate (2015-2020)
3.6.2 South Asia Advanced Cell Therapies Sales Volume Capacity, Revenue, Price and Gross Margin (2015-2020)
3.7 Southeast Asia Advanced Cell Therapies Sales Volume (2015-2020)
3.7.1 Southeast Asia Advanced Cell Therapies Sales Volume Growth Rate (2015-2020)
3.7.2 Southeast Asia Advanced Cell Therapies Sales Volume Capacity, Revenue, Price and Gross Margin (2015-2020)
3.8 Middle East Advanced Cell Therapies Sales Volume (2015-2020)
3.8.1 Middle East Advanced Cell Therapies Sales Volume Growth Rate (2015-2020)
3.8.2 Middle East Advanced Cell Therapies Sales Volume Capacity, Revenue, Price and Gross Margin (2015-2020)
3.9 Africa Advanced Cell Therapies Sales Volume (2015-2020)
3.9.1 Africa Advanced Cell Therapies Sales Volume Growth Rate (2015-2020)
3.9.2 Africa Advanced Cell Therapies Sales Volume Capacity, Revenue, Price and Gross Margin (2015-2020)
3.10 Oceania Advanced Cell Therapies Sales Volume (2015-2020)
3.10.1 Oceania Advanced Cell Therapies Sales Volume Growth Rate (2015-2020)
3.10.2 Oceania Advanced Cell Therapies Sales Volume Capacity, Revenue, Price and Gross Margin (2015-2020)
3.11 South America Advanced Cell Therapies Sales Volume (2015-2020)
3.11.1 South America Advanced Cell Therapies Sales Volume Growth Rate (2015-2020)
3.11.2 South America Advanced Cell Therapies Sales Volume Capacity, Revenue, Price and Gross Margin (2015-2020)
3.12 Rest of the World Advanced Cell Therapies Sales Volume (2015-2020)
3.12.1 Rest of the World Advanced Cell Therapies Sales Volume Growth Rate (2015-2020)
3.12.2 Rest of the World Advanced Cell Therapies Sales Volume Capacity, Revenue, Price and Gross Margin (2015-2020)
4 North America
4.1 North America Advanced Cell Therapies Consumption by Countries
4.2 United States
4.3 Canada
4.4 Mexico
5 East Asia
5.1 East Asia Advanced Cell Therapies Consumption by Countries
5.2 China
5.3 Japan
5.4 South Korea
6 Europe
6.1 Europe Advanced Cell Therapies Consumption by Countries
6.2 Germany
6.3 United Kingdom
6.4 France
6.5 Italy
6.6 Russia
6.7 Spain
6.8 Netherlands
6.9 Switzerland
6.10 Poland
7 South Asia
7.1 South Asia Advanced Cell Therapies Consumption by Countries
7.2 India
7.3 Pakistan
7.4 Bangladesh
8 Southeast Asia
8.1 Southeast Asia Advanced Cell Therapies Consumption by Countries
8.2 Indonesia
8.3 Thailand
8.4 Singapore
8.5 Malaysia
8.6 Philippines
8.7 Vietnam
8.8 Myanmar
9 Middle East
9.1 Middle East Advanced Cell Therapies Consumption by Countries
9.2 Turkey
9.3 Saudi Arabia
9.4 Iran
9.5 United Arab Emirates
9.6 Israel
9.7 Iraq
9.8 Qatar
9.9 Kuwait
9.10 Oman
10 Africa
10.1 Africa Advanced Cell Therapies Consumption by Countries
10.2 Nigeria
10.3 South Africa
10.4 Egypt
10.5 Algeria
10.6 Morocco
11 Oceania
11.1 Oceania Advanced Cell Therapies Consumption by Countries
11.2 Australia
11.3 New Zealand
12 South America
12.1 South America Advanced Cell Therapies Consumption by Countries
12.2 Brazil
12.3 Argentina
12.4 Columbia
12.5 Chile
12.6 Venezuela
12.7 Peru
12.8 Puerto Rico
12.9 Ecuador
13 Rest of the World
13.1 Rest of the World Advanced Cell Therapies Consumption by Countries
13.2 Kazakhstan
14 Sales Volume, Sales Revenue, Sales Price Trend by Type
14.1 Global Advanced Cell Therapies Sales Volume Market Share by Type (2015-2020)
14.2 Global Advanced Cell Therapies Sales Revenue Market Share by Type (2015-2020)
14.3 Global Advanced Cell Therapies Sales Price by Type (2015-2020)
15 Consumption Analysis by Application
15.1 Global Advanced Cell Therapies Consumption Volume by Application (2015-2020)
15.2 Global Advanced Cell Therapies Consumption Value by Application (2015-2020)
16 Company Profiles and Key Figures in Advanced Cell Therapies Business
16.1 FRC Blood Service
16.1.1 FRC Blood Service Company Profile
16.1.2 FRC Blood Service Advanced Cell Therapies Product Specification
16.1.3 FRC Blood Service Advanced Cell Therapies Production Capacity, Revenue, Price and Gross Margin (2015-2020)
16.2 Okyanos
16.2.1 Okyanos Company Profile
16.2.2 Okyanos Advanced Cell Therapies Product Specification
16.2.3 Okyanos Advanced Cell Therapies Production Capacity, Revenue, Price and Gross Margin (2015-2020)
16.3 Advanced Cell Technology, Inc
16.3.1 Advanced Cell Technology, Inc Company Profile
16.3.2 Advanced Cell Technology, Inc Advanced Cell Therapies Product Specification
16.3.3 Advanced Cell Technology, Inc Advanced Cell Therapies Production Capacity, Revenue, Price and Gross Margin (2015-2020)
16.4 Fujifilm
16.4.1 Fujifilm Company Profile
16.4.2 Fujifilm Advanced Cell Therapies Product Specification
16.4.3 Fujifilm Advanced Cell Therapies Production Capacity, Revenue, Price and Gross Margin (2015-2020)
16.5 Gamida Cell
16.5.1 Gamida Cell Company Profile
16.5.2 Gamida Cell Advanced Cell Therapies Product Specification
16.5.3 Gamida Cell Advanced Cell Therapies Production Capacity, Revenue, Price and Gross Margin (2015-2020)
16.6 Vericel
16.6.1 Vericel Company Profile
16.6.2 Vericel Advanced Cell Therapies Product Specification
16.6.3 Vericel Advanced Cell Therapies Production Capacity, Revenue, Price and Gross Margin (2015-2020)
16.7 BioXcellerator
16.7.1 BioXcellerator Company Profile
16.7.2 BioXcellerator Advanced Cell Therapies Product Specification
16.7.3 BioXcellerator Advanced Cell Therapies Production Capacity, Revenue, Price and Gross Margin (2015-2020)
16.8 Kolon TissueGene
16.8.1 Kolon TissueGene Company Profile
16.8.2 Kolon TissueGene Advanced Cell Therapies Product Specification
16.8.3 Kolon TissueGene Advanced Cell Therapies Production Capacity, Revenue, Price and Gross Margin (2015-2020)
16.9 Locate Bio Limited
16.9.1 Locate Bio Limited Company Profile
16.9.2 Locate Bio Limited Advanced Cell Therapies Product Specification
16.9.3 Locate Bio Limited Advanced Cell Therapies Production Capacity, Revenue, Price and Gross Margin (2015-2020)
16.10 Rexgenero
16.10.1 Rexgenero Company Profile
16.10.2 Rexgenero Advanced Cell Therapies Product Specification
16.10.3 Rexgenero Advanced Cell Therapies Production Capacity, Revenue, Price and Gross Margin (2015-2020)
16.11 Takura
16.11.1 Takura Company Profile
16.11.2 Takura Advanced Cell Therapies Product Specification
16.11.3 Takura Advanced Cell Therapies Production Capacity, Revenue, Price and Gross Margin (2015-2020)
16.12 Autolus
16.12.1 Autolus Company Profile
16.12.2 Autolus Advanced Cell Therapies Product Specification
16.12.3 Autolus Advanced Cell Therapies Production Capacity, Revenue, Price and Gross Margin (2015-2020)
17 Advanced Cell Therapies Manufacturing Cost Analysis
17.1 Advanced Cell Therapies Key Raw Materials Analysis
17.1.1 Key Raw Materials
17.2 Proportion of Manufacturing Cost Structure
17.3 Manufacturing Process Analysis of Advanced Cell Therapies
17.4 Advanced Cell Therapies Industrial Chain Analysis
18 Marketing Channel, Distributors and Customers
18.1 Marketing Channel
18.2 Advanced Cell Therapies Distributors List
18.3 Advanced Cell Therapies Customers
19 Market Dynamics
19.1 Market Trends
19.2 Opportunities and Drivers
19.3 Challenges
19.4 Porter's Five Forces Analysis
20 Production and Supply Forecast
20.1 Global Forecasted Production of Advanced Cell Therapies (2021-2026)
20.2 Global Forecasted Revenue of Advanced Cell Therapies (2021-2026)
20.3 Global Forecasted Price of Advanced Cell Therapies (2015-2026)
20.4 Global Forecasted Production of Advanced Cell Therapies by Region (2021-2026)
20.4.1 North America Advanced Cell Therapies Production, Revenue Forecast (2021-2026)
20.4.2 East Asia Advanced Cell Therapies Production, Revenue Forecast (2021-2026)
20.4.3 Europe Advanced Cell Therapies Production, Revenue Forecast (2021-2026)
20.4.4 South Asia Advanced Cell Therapies Production, Revenue Forecast (2021-2026)
20.4.5 Southeast Asia Advanced Cell Therapies Production, Revenue Forecast (2021-2026)
20.4.6 Middle East Advanced Cell Therapies Production, Revenue Forecast (2021-2026)
20.4.7 Africa Advanced Cell Therapies Production, Revenue Forecast (2021-2026)
20.4.8 Oceania Advanced Cell Therapies Production, Revenue Forecast (2021-2026)
20.4.9 South America Advanced Cell Therapies Production, Revenue Forecast (2021-2026)
20.4.10 Rest of the World Advanced Cell Therapies Production, Revenue Forecast (2021-2026)
20.5 Forecast by Type and by Application (2021-2026)
20.5.1 Global Sales Volume, Sales Revenue and Sales Price Forecast by Type (2021-2026)
20.5.2 Global Forecasted Consumption of Advanced Cell Therapies by Application (2021-2026)
21 Consumption and Demand Forecast
21.1 North America Forecasted Consumption of Advanced Cell Therapies by Country
21.2 East Asia Market Forecasted Consumption of Advanced Cell Therapies by Country
21.3 Europe Market Forecasted Consumption of Advanced Cell Therapies by Countriy
21.4 South Asia Forecasted Consumption of Advanced Cell Therapies by Country
21.5 Southeast Asia Forecasted Consumption of Advanced Cell Therapies by Country
21.6 Middle East Forecasted Consumption of Advanced Cell Therapies by Country
21.7 Africa Forecasted Consumption of Advanced Cell Therapies by Country
21.8 Oceania Forecasted Consumption of Advanced Cell Therapies by Country
21.9 South America Forecasted Consumption of Advanced Cell Therapies by Country
21.10 Rest of the world Forecasted Consumption of Advanced Cell Therapies by Country
22 Research Findings and Conclusion
23 Methodology and Data Source
23.1 Methodology/Research Approach
23.1.1 Research Programs/Design
23.1.2 Market Size Estimation
23.1.3 Market Breakdown and Data Triangulation
23.2 Data Source
23.2.1 Secondary Sources
23.2.2 Primary Sources
23.3 Disclaimer